Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease
NCT06458803
·
clinicaltrials.gov ↗
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Refractory Thrombocytopenia
Connective Tissue Diseases
Interventions
DRUG:
Eltrombopag
Sponsor
Tongji Hospital